Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00013416 · ClinicalTrials.gov registry record · Phase 2

Measurement and Prediction of Outcomes of Amplification

A Phase 2 study, sponsored by US Department of Veterans Affairs.

Completed
Registry status
Phase 2
Development phase
120
Enrollment target

NCT00013416 is a Phase 2 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 120 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00013416, a Phase 2 study, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
Phase 2
Development phase
120 participants
Enrollment target

Study Summary

The long-term goal of this research program is to develop methods to predict both the benefit and the satisfaction that hearing-impaired patients will derive from auditory amplification in daily life. This proposal has three primary objectives: (1) To determine the influence of extra-audiological variables, such as personality attributes and expectations, on the subjective outcomes of hearing aid fittings, (2) To establish a scientific basis for selection, administration, and interpretation of self-report measures of hearing aid fitting outcome, (3) To resolve the long-standing debate about the efficacy of using clinically measured loudness perception data in hearing aid prescriptions.

Interventions

  • PROCEDURE Hearing

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 1999-10
Est. Completion 2002-09
Phase Phase 2

Sponsor

US Department of Veterans Affairs

632 total trials

What the Registry Record Tells You About NCT00013416

The ClinicalTrials.gov registry entry for NCT00013416 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Hearing is the first listed.

NCT00013416 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00013416 about?

NCT00013416 is a clinical study titled "Measurement and Prediction of Outcomes of Amplification". The long-term goal of this research program is to develop methods to predict both the benefit and the satisfaction that hearing-impaired patients will derive from auditory amplification in daily life. This proposal has three primary objectives: (1) To determine the influence of extra-audiological va...

What is the current status of trial NCT00013416?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 1999-10. Estimated completion is 2002-09.

What interventions are being tested in trial NCT00013416?

The interventions under investigation include: Hearing (PROCEDURE).

Who is sponsoring clinical trial NCT00013416?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.